NOMACOPAN ( DrugBank: Nomacopan )

1 disease

告示番号	疾患名（ページ内リンク）	臨床試験数
162	類天疱瘡（後天性表皮水疱症を含む。）	2

162. 類天疱瘡（後天性表皮水疱症を含む。）

臨床試験数 : 83 / 薬物数 : 128 - (DrugBank : 51) / 標的遺伝子数 : 33 - 標的パスウェイ数 : 142

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-005987-67-DE (EUCTR)	22/12/2021	16/07/2021	A study to see if 24-weeks of treatment with nomacopanworks and is safe in adult patients with bullo ...	A randomized, part A partial blinded and part B double blinded, placebo-controlled 24-week clinical ...	moderate to severe bullous pemphigoid MedDRA version: 21.1;Level: LLT;Classification code 10006567;T ...	Product Name: nomacopan Product Code: rVA576 INN or Proposed INN: NOMACOPAN Other descriptive name: rVA ...	Akari Therapeutics Plc	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	48	Phase 3	United States;Germany
2	NCT05061771 (ClinicalTrials.gov)	September 2021	15/9/2021	NomacopanTherapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid The ...	A Randomized, Part A Partial Blinded and Part B Double Blinded, Placebo-controlled 24-week Clinical ...	Bullous Pemphigoid	Drug: nomacopan (rVA576);Other: Placebo	AKARI Therapeutics	NULL	Not yet recruiting	18 Years	99 Years	All	148	Phase 3	NULL

First Previous1Next Last